WAVE Life Sciences (WVE) Tops Q4 EPS by 34c

WAVE Life Sciences (NASDAQ: WVE) reported Q4 EPS of $0.17, $0.34 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $83.75 million versus the consensus estimate of $20.72 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours
• PVH Corp. (PVH) Tops Q1 EPS by 19c, Offers Guidance